Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology

Completed

Conditions studied: Patients With Lung, Breast, Head and Neck, or Pelvic Malignancies

In brief

The goals of this study are to assess the feasibility of weekly administration of site specific patient reported assessments using an electronic platform and to explore the correlation between patient reported outcomes as well as known dosimetric prognostic factors in patients with lung, breast, head and neck, or pelvic malignancies

Key facts

Study ID

NCT02756767

Run by

Abramson Cancer Center at Penn Medicine

People needed

75

Starts

2016-04-01

Expected to finish

2021-04-01

Last updated by the study team

2021-06-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with breast cancer, lung cancer, head and neck cancer, or gynecologic cancer receiving definitive external beam radiotherapy.
• Must be ≥ 18 years of age
• Able to read, write, and speak English in order to complete patient reported outcomes.
• Patients will be approached about the study at the time of consultation or at the time of simulation by their treating physicians or by a research coordinator. All patients must sign a study-specific informed consent to participate. All patients, including those who do not choose to consent to the study, will be provided with a short survey to assess health literacy using the eHealth Literacy Scale (eHEALS).
• For those not consenting to the study, the survey will be de-identified and will also ask for basic demographic information including age grouping, race, education level, and type of cancer.

Where it is running

• Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.